succinobucol has been researched along with HIV Coinfection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gómez, G; Lagakos, SW | 1 |
1 other study(ies) available for succinobucol and HIV Coinfection
Article | Year |
---|---|
Statistical considerations when using a composite endpoint for comparing treatment groups.
Topics: Acute Coronary Syndrome; AIDS Vaccines; Anti-HIV Agents; Anticholesteremic Agents; Biostatistics; Endpoint Determination; HIV Infections; Humans; Probucol; Randomized Controlled Trials as Topic | 2013 |